Michael O Falster

27PUBLICATIONS
75CO-AUTHORS
Major global burdens of diseasePharmaceutical delivery technologiesPharmacogenomicsCardiology (incl. cardiovascular diseases)Clinical chemistry (incl. diagnostics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Aug 17, 2026
Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes.

|Jul 28, 2026
Trends in publicly subsidized and private access to GLP-1 medicines indicated for type 2 diabetes in Australia, 2020-2025.

|Mar 31, 2026
Uptake and Costs of the 60-Day Dispensing Policy for Antihypertensive Medicines in Australia: A Mixed Methods Study.

Tian Wang, Huy L Nguyen, Isabella Tan

|Mar 28, 2026
Cardiovascular Medicine Use Among Adults With ADHD: A Nationwide Study in Australia.

Masako Araki, Helga Zoega, Malcolm Gillies

|Oct 15, 2025
Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset.

Angela Kathy Li, Sradha Kotwal, Hannah Wallace

|Jul 16, 2025
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset.

Hannah Wallace, James Wick, Brendon L Neuen

Pageof 5

Frequent Collaborators

14 joint publications

Sallie-Anne Pearson

9 joint publications

Julianna de Oliveira Costa

8 joint publications

Jialing Lin

6 joint publications

Brendon Neuen